Verus Pharmaceuticals
 | This article includes a list of general references, but it lacks sufficient corresponding inline citations. (June 2019) |
Twinject | |
| Website | www.veruspharm.com |
|---|---|
Verus Pharmaceuticals was a privately held pharmaceutical company based in
allergies
and related diseases and conditions, specifically in children.
Verus is best known for its development and manufacturing of
Paladin Labs for manufacturing and distribution in Canada (released in September 2006.) The licence for manufacturing and distribution in Europe (and option for worldwide distribution) was sold to UCB.[citation needed
]
Verus Pharmaceuticals was dissolved in March 2008 after selling its Twinject product to Sciele Pharma for $29 million.
In 2009, Verus filed a lawsuit against AstraZeneca and Tika Lakemedel, "seeking $1.3 billion on claims of fraud, breach of contract, and conversion."[1]
See also
- List of companies headquartered in San Diego, California
- Pharmaceutical company
- Twinject
References
- ^ "Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB". BioSpace. Retrieved May 27, 2020.
- "Coming of Age: Pediatric Pharmaceuticals Get Some Attention From Legislators And Venture Capitalists", Healthcare Corporate Finance News, June 2005.
- Verus Pharmaceuticals official website
- Twinject official website